Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008935:Mitoguazone / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity
D006146:Guanidines; D014747:Vinblastine; D008935:Mitoguazone